ARCHIVES

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Ronald Levy, George Stevenson To Share First Hammer Prize; President Reappoints Hammer

December 3, 1982

FDA Subcommittee Leaning Toward Mouse-Dog Drug Testing New Preclinical Toxicity-Protocol

July 20, 1979

NCAB Subcommittee Urges New Centers Categories, Recognition Of More New Comprehensive Centers

March 28, 1975

Nexavar Improves PFS In Phase III Trial

January 25, 2013

For Research Projects In Cancer Therapy

March 1, 1996

Clinton’s FY97 Budget Sees $12.4 Billion For NIH, $2.28B For NCI

March 22, 1996